Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2

Clinical Immunology

Volumn 114, Issue 1, 2005, Pages 70-78

  Ayyoub, Maha ^a   Merlo, Andrea ^a   Hesdorffer, Charles S ^a   Speiser, Daniel ^b   Rimoldi, Donata ^b   Cerottini, Jean Charles ^b   Ritter, Gerd ^c   Chen, Yao Tseng ^d   Old, Lloyd J ^c   Stevanovic, Stefan ^e   Valmori, Danila ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cancer; CD4 + T cells; Immunotherapy; SSX 2; Tumor antigen

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; HLA A2 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; PEPTIDE DERIVATIVE; RECOMBINANT PROTEIN; SSX 2 PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; EAR RECONSTRUCTION; ETHNOLOGY; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; HELPER CELL; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; SSX 2 GENE; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; VACCINATION;

ALLELES; AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HLA-DR3 ANTIGEN; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; REPRESSOR PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 10444238427     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.08.014     Document Type: Article

References (35)

1. M.J. Scanlan, A.O. Gure, A.A. Jungbluth, L.J. Old, and Y.T. Chen Cancer/testis antigens: an expanding family of targets for cancer immunotherapy Immunol. Rev. 188 2002 22 32
2. L.J. Old Cancer/testis (CT) antigens-A new link between gametogenesis and cancer Cancer Immun. 1 2001 1
3. O. Tureci, Y.T. Chen, U. Sahin, A.O. Gure, C. Zwick, C. Villena, S. Tsang, G. Seitz, L.J. Old, and M. Pfreundschuh Expression of SSX genes in human tumors Int. J. Cancer 77 1998 19 23
4. M. Ayyoub, M. Brehm, G. Metthez, S. Talbot, V. Dutoit, R.N. Taub, M.L. Keohan, A.O. Gure, Y.T. Chen, B. Williamson, A.A. Jungbluth, L.J. Old, C.S. Hesdorffer, and D. Valmori SSX antigens as tumor vaccine targets in human sarcoma Cancer Immun. 3 2003 13
5. N. Naka, N. Araki, H. Nakanishi, K. Itoh, M. Mano, S. Ishiguro, D.R. de Bruijn, A. Myoui, T. Ueda, and H. Yoshikawa Expression of SSX genes in human osteosarcomas Int. J. Cancer 98 2002 640 642
6. C.H. Chen, G.J. Chen, H.S. Lee, G.T. Huang, P.M. Yang, L.J. Tsai, D.S. Chen, and J.C. Sheu Expressions of cancer-testis antigens in human hepatocellular carcinomas Cancer Lett. 164 2001 189 195
7. O. Tureci, U. Sahin, I. Schobert, M. Koslowski, H. Scmitt, H.J. Schild, F. Stenner, G. Seitz, H.G. Rammensee, and M. Pfreundschuh The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40 Cancer Res. 56 1996 4766 4772
8. M. Ayyoub, S. Stevanovic, U. Sahin, P. Guillaume, C. Servis, D. Rimoldi, D. Valmori, P. Romero, J.C. Cerottini, H.G. Rammensee, M. Pfreundschuh, D. Speiser, and F. Levy Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma J. Immunol. 168 2002 1717 1722
9. + T cells are selectively expanded during immune responses to antigen expressing tumors in melanoma patients Cancer Res. 63 2003 5601 5606
10. V. Rubio-Godoy, M. Ayyoub, V. Dutoit, C. Servis, A. Schink, D. Rimoldi, P. Romero, J.C. Cerottini, R. Simon, Y. Zhao, R.A. Houghten, C. Pinilla, and D. Valmori Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity Eur. J. Immunol. 32 2002 2292 2299
11. + T cells J. Immunol. 172 2004 7206 7211
12. + T cells in association with HLA-DR J. Clin. Invest. 113 2004 1225 1233
13. T.F. Tang, J. Wang, R. Slack, Y.S. Lin, L. Li, U. Heine, J. Ng, R.J. Hartzman, and C. Katovich Hurley DRB1*03 diversity and DRB3 associations in five major population groups in the United States Hum. Immunol. 63 2002 221 228
14. + T cell response to the cancer testis antigen NY-ESO-1 in melanoma patients Cancer Res. 60 2000 4499 4506
15. E. Stockert, E. Jager, Y.T. Chen, M.J. Scanlan, I. Gout, J. Karbach, M. Arand, A. Knuth, and L.J. Old A survey of the humoral immune response of cancer patients to a panel of human tumor antigens J. Exp. Med. 187 1998 1349 1354
16. H. Rammensee, J. Bachmann, N.P. Emmerich, O.A. Bachor, and S. Stevanovic SYFPEITHI: database for MHC ligands and peptide motifs Immunogenetics 50 1999 213 219
17. Y.T. Chen, M.J. Scanlan, U. Sahin, O. Tureci, A.O. Gure, S.L. Tsang, B. Williamson, E. Stockert, M. Pfreundschuh, and L.J. Old A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening Proc. Natl. Acad. Sci. U. S. A. 94 1997 1914 1918
18. O. Tureci, U. Sahin, C. Zwick, M. Koslowski, G. Seitz, and M. Pfreundschuh Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens Proc. Natl. Acad. Sci. U. S. A. 95 1998 5211 5216
19. + T cells Cancer Res. 60 2000 4946 4952
20. + T cell epitopes from NY-ESO-1 presented by HLA-DR molecules J. Immunol. 165 2000 1153 1159
21. E. Jäger, Y.T. Chen, J.W. Drijfhout, J. Karbach, M. Ringhoffer, D. Jäger, M. Arand, H. Wada, Y. Noguchi, E. Stockert, L.J. Old, and A. Knuth Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes J. Exp. Med. 187 1998 265 270
22. S. Gnjatic, Y. Nagata, E. Jager, E. Stockert, S. Shankara, B.L. Roberts, G.P. Mazzara, S.Y. Lee, P.R. Dunbar, B. Dupont, V. Cerundolo, G. Ritter, Y.T. Chen, A. Knuth, and L.J. Old Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele Proc. Natl. Acad. Sci. U. S. A. 97 2000 10917 10922
23. U. Sahin, O. Tureci, H. Schmitt, B. Cochlovius, T. Johannes, R. Schmits, F. Stenner, G. Luo, I. Schobert, and M. Pfreundschuh Human neoplasms elicit multiple specific immune responses in the autologous host Proc. Natl. Acad. Sci. U. S. A. 92 1995 11810 11813
24. R.E. Toes, F. Ossendorp, R. Offringa, and C.J. Melief CD4 T cells and their role in antitumor immune responses J. Exp. Med. 189 1999 753 756
25. K. Hung, R. Hayashi, A. Lafond-Walker, C. Lowenstein, D. Pardoll, and H. Levitsky The central role of CD4(+) T cells in the antitumor immune response J. Exp. Med. 188 1998 2357 2368
26. R.F. James, S. Edwards, K.M. Hui, P.D. Bassett, and F. Grosveld The effect of class II gene transfection on the tumourigenicity of the H-2K-negative mouse leukaemia cell line K36.16 Immunology 72 1991 213 218
27. D. Mumberg, P.A. Monach, S. Wanderling, M. Philip, A.Y. Toledano, R.D. Schreiber, and H. Schreiber CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma Proc. Natl. Acad. Sci. U. S. A. 96 1999 8633 8638
28. + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells Immunity 12 2000 677 686
29. + T cells in antitumor immunity Trends Immunol. 22 2001 269 276
30. + regulatory T cells and their ligands: implications for immunotherapy Immunity 20 2004 107 118
31. A.O. Gure, O. Tureci, U. Sahin, S. Tsang, M.J. Scanlan, E. Jäger, A. Knuth, M. Pfreundschuh, L.J. Old, and Y.T. Chen SSX: a multigene family with several members transcribed in normal testis and human cancer Int. J. Cancer 72 1997 965 971
32. + T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing Proc. Natl. Acad. Sci. U. S. A. 98 2001 4587 4592
33. + T cells Cancer Res. 62 2002 213 218
34. + T-cell epitopes on the tumor antigen MAGE-3 Blood 101 2003 1038 1044
35. T. Sturniolo, E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, U. Sahin, M. Braxenthaler, F. Gallazzi, M.P. Protti, F. Sinigaglia, and J. Hammer Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices Nat. Biotechnol. 17 1999 555 561